HIGHLIGHTS
- who: Phosphorus dendrimers and colleagues from the Universitu00e9 Descartes, PRES Sorbonne Citu00e9, CNRS UMR, Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologique, rue des Saints Peres, France CQM-Centro de Quu00ed=mica Madeira, Universidade Madeira, have published the article: Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics, in the Journal: (JOURNAL)
- what: In the drug delivery realm, the main objective of dendrimer application is to improve the therapeutic outcomes of the loaded drugs, such as their pharmacokinetic (PK)/pharmacodynamic (PD) profiles.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.